Zobrazeno 1 - 10
of 17
pro vyhledávání: '"P. M. J. Stuyt"'
Autor:
B. Kortmann, A.F.H. Stalenhoef, P. M. J. Stuyt, A. A. Kroon, P. J. Lansberg, A. F. J. De Haan, J.J.P. Kastelein
Publikováno v:
Journal of internal medicine, 234(1), 77-82. Wiley-Blackwell
Objectives. To compare the efficacy and safety of increasing doses (0, 10, 20 and 40 mg day−1, each dose for 6 weeks) of the inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, simvastatin and pravastatin, in the treatment of primary hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faafe270e2dc65584e6408bc2234dc24
https://doi.org/10.1111/j.1365-2796.1993.tb00708.x
https://doi.org/10.1111/j.1365-2796.1993.tb00708.x
Autor:
Denise E. Van Diermen, Anton F. H. Stalenhoef, Yuanhong Ma, John J.P. Kastelein, Augueste Sturk, John D. Brunzell, T. Bruin, Michael R. Hayden, P. M. J. Stuyt, Howard E. Henderson
Publikováno v:
European Journal of Biochemistry / FEBS, 208(2), 267-272. Wiley-Blackwell
Here we report on the molecular defect that leads to a deficiency of lipoprotein lipase (LPL) activity in a proband of Dutch descent. Southern-blot analysis of the LPL gene from the patient did not reveal any major DNA rearrangements. Sequencing of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c700f783153dbfe69c6756a4fdec95
https://doi.org/10.1111/j.1432-1033.1992.tb17182.x
https://doi.org/10.1111/j.1432-1033.1992.tb17182.x
Publikováno v:
The Netherlands journal of medicine. 63(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4bcad6f738359032cafbf4640d0d8748
https://pubmed.ncbi.nlm.nih.gov/15719853
https://pubmed.ncbi.nlm.nih.gov/15719853
Publikováno v:
The Netherlands journal of medicine. 62(3)
Internal medicine is a broad medical speciality and choosing the residency programme opens up a variety of career tracks. Despite this broad choice of subspecialities, we found that within our residency programme for internal medicine in the Nijmegen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::672e1ea9273d928dc0ca22ad57606d51
https://pubmed.ncbi.nlm.nih.gov/15209476
https://pubmed.ncbi.nlm.nih.gov/15209476
Publikováno v:
The Netherlands journal of medicine. 61(11)
Medical textbooks are an important aid in the process of diagnosing and treating patients. Medical students use these books to acquire the skills necessary for this process, while medical teachers and experienced doctors use them for teaching these c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::92b0ab874f36dbbcd71bf3afb0d74623
https://pubmed.ncbi.nlm.nih.gov/14768723
https://pubmed.ncbi.nlm.nih.gov/14768723
Autor:
A F H, Stalenhoef, P M J, Stuyt
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 146(41)
The introduction of statins has been a breakthrough in the treatment of hypercholesterolaemia. Statins are safe and effective in reducing the risk of coronary heart disease in the general population. The 'Heart protection study' has provided evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91aa778187b8c0a58c50256681bcf5b7
https://pubmed.ncbi.nlm.nih.gov/12518529
https://pubmed.ncbi.nlm.nih.gov/12518529
Autor:
P. M. J. Stuyt, Pieternel van Heijst, Pierre N.M. Demacker, Anton F. H. Stalenhoef, Magda P.C. Hectors, Janine M Vogelaar, S.J.H. Bredie
Publikováno v:
Atherosclerosis, 138, 301-312
Atherosclerosis, 138, pp. 301-312
Atherosclerosis, 138, pp. 301-312
To gain more insight into the accumulation of β -very low density lipoprotein ( β -VLDL) in familial dysbetalipoproteinemia (FD), we followed the courses of the levels of retinyl palmitate (rp), α -tocopherol ( α -T) and apolipoprotein (apo) B-48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::383d8b360c19e760a6fb3ec93c9f5f2c
https://pubmed.ncbi.nlm.nih.gov/9690913
https://pubmed.ncbi.nlm.nih.gov/9690913
Publikováno v:
Journal of internal medicine. 230(2)
The long-term effects (66 weeks) of simvastatin (40 mg in one or two doses per day), an inhibitor of HMG CoA-reductase, were evaluated in 12 patients with familial dysbetalipoproteinaemia (type III hyperlipoproteinaemia). Simvastatin had a persistent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b0b22aabf38ec55d406c3d11ce239d7
https://pubmed.ncbi.nlm.nih.gov/1865167
https://pubmed.ncbi.nlm.nih.gov/1865167
Autor:
P. M. J. Stuyt, Bé Wieringa, H.-H. Ropers, A. E H. Stalenhoef, Hubert J.M. Smeets, Jozef Poddighe
Publikováno v:
Journal of Lipid Research, Vol 29, Iss 9, Pp 1231-1237 (1988)
A procedure based on selective hybridization with allele-specific oligonucleotides was developed for typing apolipoprotein E variants from human genomic DNAs. Two sets of oligonucleotides were synthesized and used to discriminate either between epsil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f6e418ec7dd1ef94eb1dcaa2273771
https://doi.org/10.1016/s0022-2275(20)38459-5
https://doi.org/10.1016/s0022-2275(20)38459-5
Autor:
C. H. Kleinbloesem, P. van Brummelen, J. A. van de Linde, D. D. Breimer, A. L. M. Kerremans, H. J. Cremers, J. F. Rodrigues de Miranda, C. A. M. van Ginneken, F. W. J. Gribnau, M. Schols, J. Mooy, M. van Hooff, M. A. van Baak, K. H. Rahn, A. M. Soeterboek, M. van Thiel, P. Westra, G. A. Vermeer, H. H. van Rooy, I. M. Pirovano, W. Soudijn, J. J. H. M. Lohman, P. M. Hooymans, M. T. J. M. Verhey, B. F. M. Pluym, F. W. H. M. Merkus, H. H. W. Thijssen, L. G. Baars, M. J. Reijnders, J. H. T. Wagenvoort, M. W. J. A. Fieren, W. H. F. Goessens, M. F. Michel, P. M. Edelbroek, F. G. Zitman, J. N. Schreuder, H. G. M. Rooymans, F. A. de Wolff, Ch. A. Hekster, T. B. Vree, W. H. J. Jennen, F. T. J. Verstappen, J. Salemans, J. W. M. Lenders, J. Fennis, Th. Thien, H. Houben, R. A. Binkhorst, A. van 't Laar, P. P. Koopmans, P. A. M. van Hees, W. H. L. Hoefnagels, F. T. M. Huysmans, A. J. J. Woittiez, G. J. Wenting, F. H. M. Derkx, M. A. D. H. Schalekamp, G. E. M. G. Storms, J. A. Lutterman, E. de Nobel, J. M. A. Sitsen, W. de Jong, P. M. J. Stuyt, A. F. H. Stalenhoef, P. N. M. Demacker, B. Oosterhuis, R. J. M.ten Berge, N. P. Sauerwein, E. Endert, P. Th. A. Schellekens, C. J. van Boxtel, G. K. Terpstra, J. A. M. Raaijmakers, G. A. Wassink, J. Kreukniet, J. C. Bakker, A. de Vries-v. Rossen, W. K. Bleeker, J. G. R. Ufkes, R. F. van Rosevelt, J. A. van Mourik, J. A. Loos, H. G. J. Brummelhuis, J. J. Schalken, J. W. J. Lammers, A. J. Beld, C. L. A. van Herwaarden
Publikováno v:
Pharmaceutisch Weekblad. 5:191-196
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffdf9c1a11f2bb70473524c01171531f
https://doi.org/10.1007/bf01961482
https://doi.org/10.1007/bf01961482